Clinical trial

A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers

NCT05738993

Study summary

ClinicalTrials.gov

A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention BCD-178 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Perjeta Normalized identity: Perjeta View linked drug · Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-08-08

PhasePHASE1

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

BCD-178DRUG

PerjetaDRUG · verified · RxNorm: Perjeta

Sponsors & collaborators

Biocadlead sponsor

Mapped research locations

Saint PetersburgRussia2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05738993 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.